Immunomodulating therapy in viral myocarditis: effects of tumour necrosis factor, interleukin 2 and anti-interleukin-2 receptor antibody in an animal model.
Matsumori
A
A
Department of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
Yamada
T
T
Kawai
C
C
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D004686:Encephalomyocarditis virus; D004769:Enterovirus Infections / Q000628:therapy*; D007165:Immunosuppression Therapy; D007376:Interleukin-2 / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D009205:Myocarditis / Q000382:microbiology* / Q000628:therapy*; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D007376:Interleukin-2; D015375:Receptors, Interleukin-2; D014409:Tumor Necrosis Factor-alpha